PHASE-II STUDY OF DOXORUBICIN (DOX) AND PACLITAXEL (TAX) GIVEN PRIOR TO STANDARD CISPLATIN (P) AND ETOPOSIDE (E) IN PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER (SCLC)

Authors
MAUER A LAD T HOFFMAN P ARIETA R GABRYS J SCIORTINO D VOKES E
Citation
A. Mauer et al., PHASE-II STUDY OF DOXORUBICIN (DOX) AND PACLITAXEL (TAX) GIVEN PRIOR TO STANDARD CISPLATIN (P) AND ETOPOSIDE (E) IN PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER (SCLC), Annals of oncology, 9, 1998, pp. 655-655
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
2
Pages
655 - 655
Database
ISI
SICI code
0923-7534(1998)9:<655:PSOD(A>2.0.ZU;2-4